1-4 of 4
Narendranath Epperla, MD MS
Close
Sort by
Journal Articles

Intensive Induction Regimens after Deferring Initial Therapy Are Not Associated with Improved Progression-Free or Overall Survival in Patients with Mantle Cell Lymphoma (MCL)

Krithika Shanmugasundaram, MD, Subir Goyal, MPH, MBBS, Jeffrey M. Switchenko, PhD MS, Oscar Calzada, BS, Michael C Churnetski, BS, Bhaskar Kolla, MBBS, Veronika Bachanova, MD PhD, James Nathan Gerson, MD, Stefan Klaus Barta, MD MRCP, MS, Max J. Gordon, MD, Alexey V Danilov, MD PhD, Natalie S Grover, MD, Stephanie Mathews, MD, Madelyn Burkart, MD, Reem Karmali, MD, Yazeed Sawalha, MD, Brian T. Hill, MD PhD, Nilanjan Ghosh, MD PhD, Steven I Park, MD, Narendranath Epperla, MD MS, David A. Bond, MD, Talha Badar, MD, Kristie A. Blum, MD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Mary Malacek, MD, Brad S. Kahl, MD, Christopher R Flowers, MD MS, Jonathon B. Cohen, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4153.
https://doi.org/10.1182/blood-2018-99-117547
Published: 2018
Journal Articles

Preliminary Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

Kami J. Maddocks, MD, Farrukh T. Awan, MD MS, Ying Huang, MA, MS, Sabarish Ayyappan, MBBS, Robert A Baiocchi, MD PhD, Narendranath Epperla, MD MS, Samantha Jaglowski, MD MPH, Basem M. William, MRCP, MD, Kristie A. Blum, MD, Beth A. Christian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4185.
https://doi.org/10.1182/blood-2018-99-117172
Published: 2018
Journal Articles

Down-Regulation of CD25 Antigen in Hairy Cell Leukemia Patients after Treatment

Mirela Anghelina, Narendranath Epperla, MD MS, Kerry A. Rogers, MD, Ling Guo, MD, Qiuhong Zhao, MS, James S. Blachly, MD, David M. Lucas, PhD, Christopher C. Oakes, Gerard Lozanski, MD, Michael R. Grever, MD, Leslie A. Andritsos, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4143.
https://doi.org/10.1182/blood-2018-99-120043
Published: 2018
Journal Articles

Recent Survival Trends in Diffuse Large B-Cell Lymphoma (DLBCL)- Did We Make Any Progress Beyond Rituximab ?

Narendranath Epperla, MD MS, Abrahão Elias Hallack Neto, MD PhD, Luciano J Costa, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4828.
https://doi.org/10.1182/blood-2018-99-109937
Published: 2018